Goldman Sachs Group INC Schedule 13G passive stakes

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have disclosed a beneficial ownership of 6.0% in Global Blockchain Acquisition Corp., holding 348,306 shares of common stock.

Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting a passive beneficial ownership of 3.4% in TC Energy Corporation as of March 31, 2025.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, indicating they no longer hold a reportable beneficial ownership stake in Stronghold Digital Mining Inc.'s Class A Common Stock.

The Goldman Sachs Group, Inc. and its affiliate Goldman Sachs & Co. LLC have reported a 2.4% beneficial ownership stake in Silexion Therapeutics Corp. as of March 31, 2025.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have jointly filed a Schedule 13G, disclosing beneficial ownership of 6.0% of Nevro Corp.'s common stock as of March 31, 2025.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting a passive beneficial ownership of 1.3% in Martin Midstream Partners L.P. as of March 31, 2025.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a beneficial ownership of 7.0% in Launch Two Acquisition Corp.'s Class A ordinary shares as of March 31, 2025.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting a beneficial ownership of 4.1% in Larimar Therapeutics, Inc. common stock as of March 31, 2025.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a beneficial ownership of 6.0% in Jackson Acquisition Co II's Class A ordinary shares.

The Goldman Sachs Group, Inc. and its affiliate Goldman Sachs & Co. LLC have reported a passive beneficial ownership of 7.4% in Heliogen, Inc.'s common stock.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have disclosed a beneficial ownership of 5.3% in Riot Platforms, Inc., holding over 18.4 million shares as of March 31, 2025.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting a passive beneficial ownership of 3.2% in HCM II Acquisition Corp's Class A ordinary shares.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a 2.8% beneficial ownership stake in Colombier Acquisition Corp II, held for ordinary course of business.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a passive beneficial ownership of 5.2% in AnaptysBio, Inc.'s common stock.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, disclosing a passive beneficial ownership of 1.3% in AMC Entertainment Holdings, Inc.'s Class A common stock.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting a passive beneficial ownership of 1.1% in WillScot Mobile Mini Holdings Corp.'s common stock.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have jointly disclosed a beneficial ownership of 6.7% in Willow Lane Acquisition Corp.'s Class A Ordinary Shares.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amendment to their Schedule 13G, reaffirming a beneficial ownership of 5.2% in Syndax Pharmaceuticals, Inc.'s common stock as of March 31, 2025.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have disclosed a passive beneficial ownership of 5.4% in Solarbank Corporation's common shares.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported beneficial ownership of 5.2% of the Ordinary Shares of Rising Dragon Acquisition Corp.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a passive beneficial ownership of 5.5% of PBF Energy Inc.'s Class A Stock as of March 31, 2025.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have disclosed a beneficial ownership of 6.7% in Oaktree Acquisition Corp III Life Sciences, holding 1,337,502 Class A ordinary shares.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a passive beneficial ownership of 5.1% in NRG Energy, Inc. as of March 31, 2025.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, disclosing a passive beneficial ownership of 3.6% in MELAR ACQUISITION CORP I's Class A Ordinary Shares.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have disclosed a 5.5% beneficial ownership stake in KORE Group Holdings, Inc., held for ordinary business purposes.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a passive beneficial ownership of 5.8% in H&E Equipment Services, Inc. common stock.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have disclosed a beneficial ownership of 6.9% in GSR III Acquisition Corp.'s Class A ordinary shares.

Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, disclosing a passive beneficial ownership of 3.9% in GENEDX HOLDINGS CORP.'s Class A common stock, indicating a reduction from a previously held stake above 5%.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, disclosing a passive beneficial ownership of 0.3% in GAN Limited's ordinary shares as of March 31, 2025.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have disclosed a passive beneficial ownership of 7.4% in Fate Therapeutics, Inc. common stock.